Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares

    NEXT STORY
    AzurRx BioPharma and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II in Exocrine Pancreatic Insufficiency (EPI)
    PREV STORY
    Achaogen Highlights Plazomicin Presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ADMA Biologics Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress

    author_avatar
    NASDAQ Market News

    Gippsland Health Alliance selects Allscripts EMR

    MELBOURNE, Australia, Nov. 06, 2017 (GLOBE NEWSWIRE) -- As a result of a competitive ...

    author_avatar
    NASDAQ Market News

    CytomX to Present at the Jefferies 2017 Global Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., May 25, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

    author_avatar
    NASDAQ Market News